Viewing Study NCT01541059


Ignite Creation Date: 2025-12-24 @ 2:38 PM
Ignite Modification Date: 2025-12-30 @ 5:57 AM
Study NCT ID: NCT01541059
Status: COMPLETED
Last Update Posted: 2025-11-19
First Post: 2012-02-20
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Postoperative Analgesia Following Wisdom Teeth Removal: Ropivacaine Versus Placebo
Sponsor: Centre Hospitalier Universitaire de Nīmes
Organization:

Study Overview

Official Title: Postoperative Analgesia in Third Molar Surgery Under General Anesthesia: Ropivacaine Versus Placebo
Status: COMPLETED
Status Verified Date: 2015-10
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: RopiMol
Brief Summary: The main objective of this study is to demonstrate the superiority of local analgesia with ropivacaine versus placebo on postoperative pain during the first 24 hours following bilateral surgery of all four third molars under general anesthesia.
Detailed Description: The secondary objectives of this study are to compare regional anesthesia by ropivacaine versus placebo for the bilateral resection of all four third molars under general anesthesia, in terms of:

A. intraoperative use of propofol and remifentanil B. postoperative pain (EVN) at different time points C. in-hospital analgesic consumption D. time to first rescue analgesic request E. time spent in the post interventional treatment room F. length of hospital stay G. side effects H. analgesic consumption at home I. analgesic consumption (total) J. patient satisfaction K. Chronic pain after surgery

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?:

Secondary ID Infos

Secondary ID Type Domain Link View
2011-004972-13 EUDRACT_NUMBER None View